![Meghan Markle and Prince Harry have reportedly been breaking etiquette by insisting on sitting next to each other at dinner parties [Image: Getty]](https://newsfortomorrow.com/wp-content/uploads/2019/08/Meghan-Markle-and-Prince-Harry-break-dinner-party-etiquette-by-225x125.jpeg)
The “Breast Imaging Market by Technology [Mammography (FFDM, Digital & 3D Mammography), Breast Ultrasound, MRI, CBCT, MBI, PET-CT, ABUS, Optical Imaging], End user (Hospitals & Clinics, Breast Care Centers, Diagnostic Imaging Centers) -Global Forecasts to 2025” report has been added to ResearchAndMarkets.com’s offering.
The Global Breast Imaging Market is projected to reach USD 5.4 billion by 2025 from USD 3.7 billion in 2020, growing at a CAGR of 8.1%.
The growth of the market is attributed to the rising incidence of breast cancer in women. According to GLOBOCON 2018, breast cancer is the most common cancer among women and one of the most important causes of death. In 2018, 2,088,849 breast cancer cases were diagnosed globally.
Furthermore, growth in the geriatric population (as age contributes to the risk of breast cancer) and changing lifestyles, which have increased the overall possibility of cancer occurrence, presence of favorable reimbursement scenario, and implementation of breast density laws in major regions will further fuel the growth of the market in near future. However, the side-effects of radiation exposure and the growing adoption of refurbished imaging systems are the major factors that are expected to restrain the growth of this market during the forecast period.
The ionizing breast imaging segment is expected to account for the largest market share during the forecast period
Based on technology, the market is segmented into ionizing imaging technologies and non-ionizing imaging technologies. Ionizing imaging technologies segment is categorized into five subsegments, namely, mammography (analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis), positron emission tomography-computed tomography (PET-CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), positron emission mammography (PEM), and cone-beam computed tomography (CBCT) technology.
While, the non-ionizing breast imaging technologies market is further sub-segmented into breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography, and optical imaging technologies. The ionizing breast imaging segment accounted for the largest share of this market in 2019, driven by the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.
The mammography segment to hold a major share of the breast imaging market over the market throughout the forecast period
Based on type, the mammography market is segmented into three major types-full-field digital mammography, analog mammography, and 3D breast tomosynthesis. Rising R&D by the key players operating in the market, technological advancements coupled with favorable reimbursement scenario in most of the developed countries is driving the growth of the mammography segment.
Europe to account for the second-largest share of the global market in 2019
The breast imaging market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. Europe accounted for the second-largest share of the breast imaging market in 2019. The growth of the breast imaging market in Europe is mainly driven by factors such as the increasing incidence of breast cancer and awareness regarding early breast cancer detection. Furthermore, factors such as the increasing number of regulatory approvals for advanced breast imaging modalities and the growing number of distribution collaborations and partnerships among market players are also supporting the growth of this market.
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Breast Imaging: Market Overview
4.2 Geographic Analysis: Breast Imaging Market, By Technology and Region
4.3 Geographic Analysis: Mammography Market, By Type and Region
4.4 Non-Ionizing Breast Imaging Market, By Type and Region
4.5 Ionizing Breast Imaging Market, By End User and Region
4.6 Geographic Snapshot of The Breast Imaging Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Incidence of Breast Cancer
5.2.1.2 Increasing Public-Private Investments, Funding, and Grants
5.2.1.3 Growing Awareness Regarding Early Detection of Breast Cancer
5.2.1.4 Technological Advancements in Breast Imaging Modalities
5.2.1.5 Growing Aging Population
5.2.2 Restraints
5.2.2.1 High Cost of Breast Imaging Systems
5.2.2.2 Stringent Regulatory Approval Procedures
5.2.3 Opportunities
5.2.3.1 Emerging Economies Offer High Growth Potential
5.2.3.2 Contract-Based Diagnostic Solutions and Mobile Solutions
5.2.4 Challenges
5.2.4.1 Side Effects of Radiation Exposure
5.2.4.2 Errors in Breast Cancer Screening and Diagnosis
5.2.4.3 Increasing Adoption of Refurbished Imaging Systems
5.3 Market Trends
5.3.1 Artificial Intelligence
5.3.2 Personalized Approach to Breast Cancer Screening
5.3.3 Multimodal Breast Imaging
5.4 Screening Guidelines for Breast Cancer
6 Breast Imaging Market, By Technology
6.1 Introduction
6.2 Ionizing Breast Imaging Technologies
6.2.1 Mammography
6.2.1.1 Full-Field Digital Mammography (Ffdm)
6.2.1.1.1 Ffdm Offers Significant Advantages Over Conventional Analog Mammography, Such As The Use of Lower Radiation Doses and Reduced Breast Compression Pressure
6.2.1.2 Analog Mammography
6.2.1.2.1 Superior Accuracy and Efficiency Offered By Digital Mammography Have Limited The Adoption of Analog Mammography
6.2.1.3 3D Breast Tomosynthesis
6.2.1.3.1 The Segment to Witness The Highest Growth Rate in The Mammography Market During The Forecast Period
6.2.2 Positron Emission Mammography (Pem)
6.2.2.1 Pem Involves Radiation Exposure Throughout The Body, Which Increases The Risk of Cancer – A Major Disadvantage Associated With This Technique
6.2.3 Positron Emission Tomography and Computed Tomography (Pet-Ct)
6.2.3.1 Combined Scans From Pet and Ct Offer More Accurate Results as Compared to The Individual Scans
6.2.4 Molecular Breast Imaging/Breast-Specific Gamma Imaging (Mbi/Bsgi)
6.2.4.1 Mbi Technique is Simple, Fast, and Highly Sensitive
6.2.5 Cone-Beam Computed Tomography (Cbct)
6.2.5.1 Cbct is The Latest Among The Long History of Breast Imaging Techniques
6.3 Non-Ionizing Breast Imaging Technologies
6.3.1 Breast Ultrasound
6.3.1.1 Low Cost, Growing Awareness, and Easy Availability of Ultrasound Devices for Breast Imaging Are Driving The Growth of This Market
6.3.2 Breast Mri
6.3.2.1 Technological Advancements in Breast Mri to Drive The Growth of This Segment
6.3.3 Automated Whole-Breast Ultrasound (AWBU)
6.3.3.1 AWBU Helps Spot Small Cancers in The Mammogram of Dense Breast
6.3.4 Breast Thermography
6.3.4.1 The Technique is Approved By Fda As ‘Adjunctive Tool’ to Be Used Alongside With Mammography
6.3.5 Electric Impedance Tomography
6.3.5.1 Metabolic Process Related Information Provided By This Technology Helps Healthcare Specialists to Select The Treatment Strategy
6.3.6 Optical Imaging
6.3.6.1 Advantages Associated With The Technology, Such As High Sensitivity, Easy Accessibility, and Lower Cost to Support The Segment Growth
7 Breast Imaging Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
7.2.1 Large Hospitals Have Been Early Adopters of Advanced Breast Imaging Systems
7.3 Diagnostic Imaging Centers
7.3.1 Increasing Number of Private Imaging Centers is Contributing to The Market Growth
7.4 Breast Care Centers
7.4.1 Increasing Inclination Toward Breast Care Centers Has Been Observed in Developed Countries
7.5 Other End Users
7.5.1 Increasing Research Activities is Supporting Growth of The Segment
8 Breast Imaging Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 US Dominated The North America Breast Imaging Market
8.2.2 Canada
8.2.2.1 Surge in The Incidence of Breast Cancer and Favorable Government Guidelines to Support The Market Growth
8.3 Europe
8.3.1 Germany
8.3.1.1 Wide Acceptance for Both Ionizing and Non-Ionizing Imaging Technologies in The Country
8.3.2 France
8.3.2.1 Growing Initiatives By Government and Modernization of Healthcare Infrastructure Fueling The Demand for Breast Imaging Equipment
8.3.3 UK
8.3.3.1 Initiatives By Public & Private Organizations to Increase Awareness About Breast Cancer
8.3.4 Italy
8.3.4.1 Evolving Regulatory Scenario for Breast Imaging and Rising Incidence of Cancer Are The Major Driving Factors
8.3.5 Spain
8.3.5.1 Growing Geriatric Population Major Factor for The Market Growth
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Presence of Universal Healthcare Reimbursement Scenario and Rising Breast Cancer Cases
8.4.2 China
8.4.2.1 Increasing Patient Pool and Government Initiatives for Healthcare Development Are Fueling The Market Growth
8.4.3 India
8.4.3.1 Government Initiatives to Improve Female Health to Drive Market Growth in India
8.4.4 Australia
8.4.4.1 Rising Research Investments and Awareness Campaigns Are The Key Factors Supporting Market Growth
8.4.5 South Korea
8.4.5.1 Supportive Government Initiatives in The Country Expected to Positively Impact Market Growth
8.4.6 Rest of Apac
8.5 Latin America
8.5.1 Brazil
8.5.1.1 Key Market in Latin America Owing to The Modernization of Healthcare Facilities
8.5.2 Mexico
8.5.2.1 Availability of Advanced Care and Increasing Awareness Programs Are Fueling The Market Growth
8.5.3 Rest of LA
8.6 Middle East & Africa
8.6.1 Improving Healthcare Infrastructure and Increasing Public-Private Investments to Drive Market Growth in The MEA Region
9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Scenario
9.3.1 Product Launches and Approvals
9.3.2 Acquisitions
9.3.3 Partnerships and Agreements
9.4 Competitive Leadership Mapping (Overall Market)
9.4.1 Competitive Leadership Mapping: Major Market Players (2018)
9.4.2 Visionary Leaders
9.4.3 Innovators
9.4.4 Dynamic Differentiators
9.4.5 Emerging Companies
9.5 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (2019)
9.5.1 Progressive Companies
9.5.2 Starting Blocks
9.5.3 Responsive Companies
9.5.4 Dynamic Companies
10 Company Profiles
10.1 Hologic, Inc.
10.2 GE Healthcare (Part of General Electric Company)
10.3 Siemens Healthcare (Part of Siemens AG)
10.4 Koninklijke Philips N.V.
10.5 Fujifilm Holdings Corporation
10.6 Canon Inc.
10.7 Aurora Healthcare US Corp.
10.8 Allengers
10.9 Dilon Technologies, Inc.
10.10 Planmed OY
10.11 Delphinus Medical Technologies, Inc.
10.12 Micrima Limited
10.13 CMR Naviscan
10.14 Supersonic Imagine
10.15 Carestream Health
10.16 Other Companies
10.16.1 Kub Technologies
10.16.2 Cura Healthcare
10.16.3 Sonocin
10.16.4 NP JSC Amico
10.16.5 Qt Ultrasound LLC
For more information about this report visit https://www.researchandmarkets.com/r/n6gfwx
View source version on businesswire.com: https://www.businesswire.com/news/home/20200414005934/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
